<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Hepatitis E</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Hepatitis E.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/hepatitis-e.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>COMPARATIVE ANALYSIS OF ANTIVIRAL THERAPIES IN CHRONIC HCV PATIENTS: CLINICAL OUTCOMES AND TREATMENT IMPLICATIONS</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-64013-bbasr-v2026i1-136-d16327e4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-64013-bbasr-v2026i1-136-d16327e4/</guid>
    <pubDate>Sat, 05 Sep 2026 00:00:00 GMT</pubDate>
    <description>Findings highlight commonly reported HCV exposure routes in this cohort, including unsafe barber visits (38.2%), unsafe therapeutic injections (31.8%), and unsafe dental procedures (24.5%), suggesting potential targets for infection control.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Hepatitis B and C Prevention, Screening, and Diagnostic Services at HIV Treatment Sites: International Epidemiology Databases to Evaluate AIDS.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-qai-0000000000003896-a601496f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-qai-0000000000003896-a601496f/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Findings point to gaps in HBV and HCV service availability at HIV treatment sites, particularly rural sites, relevant to efforts to address these infections among people receiving HIV care.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>AIDS</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta-Analysis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-jvh-70222-ec6cd0c2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-jvh-70222-ec6cd0c2/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The abstract characterizes HBV, HCV, HDV, MASLD, and alcohol use as preventable causes or contributors considered in relation to liver cancer. It states that the findings support integrating hepatocellular carcinoma surveillance into management of viral hepatitis.</description>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>Surveillance</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Acceptability and Effectiveness of Point-of-Care HCV Testing in Low- and Middle-Income Countries: A Systematic Review.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-liv-70844-6b9da0ae/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-liv-70844-6b9da0ae/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Decentralized HCV testing and care models may improve testing uptake and treatment success in LMICs, addressing the reliance on costly and technically demanding centralized laboratory services. High retention in care and cure rates support the potential for these models to advance HCV elimination goals in resource-limited settings.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Letter to the Editor: Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4254-wjh-118661-ff82a1d3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4254-wjh-118661-ff82a1d3/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors support use of generic sofosbuvir/ledipasvir in children and adolescents in Egypt and other resource-limited countries. This relevance reflects the authors&apos; stated position and the reported study findings.</description>
    <category>Hepatitis E</category>
    <category>Hepatitis C</category>
    <category>Chronic hepatitis C</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>CRISPR-based point-of-care diagnostics for viral hepatitis: from molecular design to clinical implementation</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fbioe-2026-1892898-b3b05b03/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fbioe-2026-1892898-b3b05b03/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>Faster pathogen identification could facilitate earlier therapeutic interventions and strengthen broader elimination campaigns. Decentralized testing formats offer potential to reduce specimen transit times and improve patient retention throughout diagnostic sequences.</description>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>Hepatitis A</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Revisiting Anti-HCV Seropositivity: Signal Intensity, Diagnostic Uncertainty, and the Limitations of Fixed Cut-Offs</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-diagnostics16162665-cff60faf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-diagnostics16162665-cff60faf/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>Findings suggest graded, signal-based interpretation of anti-HCV reactivity may reduce unnecessary confirmatory testing and clarify low-level reactivity in screening contexts.</description>
    <category>Hepatitis E</category>
    <category>Hepatitis C</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Gut Microbiota Recovery After Direct-Acting Antiviral Therapy for Chronic Hepatitis C: A Systematic Review and Meta-Analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-microorganisms14081843-c4d61cac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-microorganisms14081843-c4d61cac/</guid>
    <pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesis highlights unresolved questions regarding how antiviral success translates to intestinal ecosystem restoration, indicating a documented gap in characterizing associated functional and clinical outcomes.</description>
    <category>Hepatitis C</category>
    <category>Chronic hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Prenatal testing and postpartum treatment for hepatitis C virus among women with opioid use disorder</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-pmf2-70382-fb5d6fe1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-pmf2-70382-fb5d6fe1/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The observed discrepancies between recommended protocols and actual clinical practices indicate potential systemic barriers to standard care pathways for this demographic.</description>
    <category>Hepatitis E</category>
    <category>Hepatitis C</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Meeting Patients with Hepatitis C Where They Are: Lessons from the HIV Epidemic in the USA</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s11606-026-10629-7-b13e6dbd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s11606-026-10629-7-b13e6dbd/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article addresses national HCV eradication goals and advocates for equitable treatment access. It proposes a test-and-treat approach during hospital admission and reframing nonadherence as a need for support rather than a patient deficiency.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>[Silent shift: changes in the types and subtypes of hepatitis C virus in Hungarian patients over three decades (1996-2026)].</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1556-650-2026-33628-f0ad582d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1556-650-2026-33628-f0ad582d/</guid>
    <pubDate>Sun, 16 Aug 2026 00:00:00 GMT</pubDate>
    <description>The abstract states that HCV genotype monitoring can assist identification of uncommon subtypes, investigation of unexpected treatment outcomes, epidemiologic investigations, and distinguishing relapse from reinfection. These are stated roles of monitoring, not evidence that any specific intervention or surveillance system achieved those outcomes.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Targeted Wastewater Surveillance during the World Athletics Championship, Oregon, USA, 2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid3213-260537-2a842fb8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid3213-260537-2a842fb8/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Incorporating pathogen tracking into existing monitoring frameworks may supply supplementary early warning indicators during mass assembly scenarios.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Measles</category>
    <category>Influenza</category>
    <category>Hepatitis E</category>
    <category>Hepatitis A</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Time to viral load suppression with 8-week versus 12-week ravidasvir/sofosbuvir regimens among chronic hepatitis C patients in Malaysia: a non-inferiority, randomized clinical trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13741-5-f049bb89/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13741-5-f049bb89/</guid>
    <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings provide treatment-duration evidence from Malaysian adults with chronic hepatitis C and may inform further evaluation of shorter ravidasvir/sofosbuvir regimens. The abstract does not establish programmatic recommendations, population-level effectiveness, or effects on transmission or mortality.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Chronic hepatitis C</category>
    <category>Treatment</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Sex-specific burdens of acute hepatitis B and C and their attributable risk factors in 204 countries and territories, 1990-2021.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-00942-6-900f1df6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-00942-6-900f1df6/</guid>
    <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
    <description>Ongoing demographic and geographic inequalities emphasize the importance of customized intervention approaches, such as enhanced immunization campaigns, expanded diagnostic testing, improved therapeutic access, and risk reduction measures to align with international elimination targets.</description>
    <category>Hepatitis C</category>
    <category>Acute hepatitis B</category>
    <category>Hepatitis B</category>
    <category>Acute hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Viral Hepatitis</category>
    <category>COVID-19</category>
    <category>Climate and environment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf635-5be79539/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciaf635-5be79539/</guid>
    <pubDate>Wed, 19 Nov 2025 00:00:00 GMT</pubDate>
    <description>These quantitative projections help guide institutional planning for post-viral eradication monitoring programs, especially as therapeutic access widens across different regions.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>AIDS</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-23-00108-8-1089958f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-23-00108-8-1089958f/</guid>
    <pubDate>Tue, 01 Aug 2023 00:00:00 GMT</pubDate>
    <description>Ongoing cross-national viral circulation persists despite broad antiviral accessibility, potentially obstructing localized reduction initiatives. Coordinated multinational intervention frameworks appear essential to manage persistent transmission routes.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Transmission dynamics</category>
    <category>Genomic epidemiology</category>
    <category>Treatment</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>High impact of molecular surveillance on hepatitis A outbreak case detection in Sweden: a retrospective study, 2009 to 2018</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2021-26-9-1900763-51795d14/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2021-26-9-1900763-51795d14/</guid>
    <pubDate>Thu, 04 Mar 2021 00:00:00 GMT</pubDate>
    <description>This paper is relevant to genomic epidemiology and outbreak investigation because it describes the use of sequence-based typing in Swedish hepatitis A surveillance. It provides literature context on how molecular data can help organize cluster detection work.</description>
    <category>Hepatitis A</category>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41541-020-00266-4-cdac0d00/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41541-020-00266-4-cdac0d00/</guid>
    <pubDate>Mon, 11 Jan 2021 00:00:00 GMT</pubDate>
    <description>The findings suggest that obese individuals with NAFLD may have suboptimal immune responses to standard hepatitis B vaccination, potentially requiring modified vaccination strategies or monitoring in this population.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Hepatitis A</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2412-180937-ce6d55e0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2412-180937-ce6d55e0/</guid>
    <pubDate>Sat, 01 Dec 2018 00:00:00 GMT</pubDate>
    <description>The report indicates that routine hepatitis E tests may fail to identify HEV-C infection and identifies possible relevance for evaluation of unexplained hepatitis. It also describes HEV-C as a potential concern for blood product safety, without providing population-level risk estimates.</description>
    <category>Hepatitis E</category>
    <category>Treatment</category>
    <category>Genomic epidemiology</category>
    <category>Diagnostics</category>
    <category>One Health</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Hepatitis E virus infection in North Italy: high seroprevalence in swine herds and increased risk for swine workers</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1017-s0950268817002485-33df3d61/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1017-s0950268817002485-33df3d61/</guid>
    <pubDate>Fri, 17 Nov 2017 00:00:00 GMT</pubDate>
    <description>The findings provide evidence of substantial HEV serological exposure in the studied swine herds and higher measured seropositivity among the sampled swine workers than in the comparison groups. The article therefore provides occupational and animal-human interface context for HEV in the study setting, without establishing causality or current population-level surveillance status.</description>
    <category>Hepatitis E</category>
    <category>Gastroenteritis</category>
    <category>Hepatitis A</category>
    <category>One Health</category>
    <category>Climate and environment</category>
    <category>Travel medicine</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2305-161477-d21f5459/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2305-161477-d21f5459/</guid>
    <pubDate>Mon, 01 May 2017 00:00:00 GMT</pubDate>
    <description>China&apos;s perinatal transmission-targeted HBV prevention program has been highly successful and increasingly effective. Sustained effort over decades and augmented strategies will be needed to eliminate HBV transmission.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Chronic hepatitis B</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Racial differences in seroprevalence of HAV and HEV in blood donors in the Western Cape, South Africa: a clue to the predominant HEV genotype?</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1017-s0950268817000565-5a0f64c0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1017-s0950268817000565-5a0f64c0/</guid>
    <pubDate>Thu, 30 Mar 2017 00:00:00 GMT</pubDate>
    <description>The findings suggest that HEV transmission in this population may differ from the classical oro-faecal route associated with genotypes 1 and 2, potentially reflecting zoonotic transmission via dietary meat consumption and socio-economic differences. Understanding transmission routes is important for prevention strategies.</description>
    <category>Hepatitis E</category>
    <category>Gastroenteritis</category>
    <category>Hepatitis A</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Cultural drivers and health-seeking behaviours that impact on the transmission of pig-associated zoonoses in Lao People’s Democratic Republic</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-2049-9957-4-11-805c6eb8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-2049-9957-4-11-805c6eb8/</guid>
    <pubDate>Mon, 02 Mar 2015 00:00:00 GMT</pubDate>
    <description>Pig production poses significant health risks through zoonotic disease transmission, yet these diseases are substantially underreported due to similar clinical presentations and inadequate diagnostics. Understanding sociocultural drivers is crucial for disease control, requiring transdisciplinary One Health research to address social determinants of health, health-seeking behaviours, and disease reporting.</description>
    <category>Taeniasis</category>
    <category>Cysticercosis</category>
    <category>Hepatitis E</category>
    <category>Japanese Encephalitis</category>
    <category>Brucellosis</category>
    <category>Leptospirosis</category>
    <category>Trichinellosis</category>
    <category>Streptococcus suis</category>
    <category>Q fever</category>
    <category>One Health</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Completion of the entire hepatitis C virus life cycle in genetically humanized mice</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-nature12427-7ce1c442/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-nature12427-7ce1c442/</guid>
    <pubDate>Wed, 31 Jul 2013 00:00:00 GMT</pubDate>
    <description>The model provides a preclinical platform for testing antiviral drug candidates and may support vaccine efficacy evaluation for a pathogen affecting over 130 million people globally.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-1471-2334-13-288-8512e4d5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-1471-2334-13-288-8512e4d5/</guid>
    <pubDate>Mon, 24 Jun 2013 00:00:00 GMT</pubDate>
    <description>The authors concluded that Egypt faces an HCV disease burden of historical proportions, with evidence suggesting a massive epidemic at the national level and substantial ongoing transmission. They emphasized that HCV prevention must become a national priority and called for policymakers and stakeholders to introduce and implement further prevention measures targeting transmission routes.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Hepatitis E virus: the current scenario</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2012-11-026-dcdc165e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2012-11-026-dcdc165e/</guid>
    <pubDate>Mon, 01 Apr 2013 00:00:00 GMT</pubDate>
    <description>The review highlights HEV as a common cause of acute hepatitis in regions with poor sanitation, identifies high-risk groups, and discusses the relevance of an effective but not yet commercially available subunit vaccine for prevention.</description>
    <category>Hepatitis E</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-12-70177-9-1b9c7f36/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-12-70177-9-1b9c7f36/</guid>
    <pubDate>Thu, 01 Nov 2012 00:00:00 GMT</pubDate>
    <description>Reliable epidemiological metrics facilitate evidence-based health policy development, resource allocation, and tailored clinical service planning for vulnerable housing groups.</description>
    <category>Tuberculosis</category>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>HIV infection</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Selective Transmission of Hepatitis C Virus Quasi Species through a Needlestick Accident in Acute Resolving Hepatitis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1086-503040-6e67371d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1086-503040-6e67371d/</guid>
    <pubDate>Mon, 01 May 2006 00:00:00 GMT</pubDate>
    <description>The findings illustrate selective transmission dynamics of HCV quasi species in occupational needlestick exposures and suggest that genetic homogeneity of transmitted variants may influence clinical outcomes such as spontaneous viral clearance.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Genomic epidemiology</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Genomic study</category>
  </item>
</channel>
</rss>
